Patent · US Expired

Phenylpyridinecarbonylpiperazinederivative

US7196080B2 · kind B2 · utility

3Cited by
1References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 13, 2002
Grant dateMar 27, 2007
Priority date
Expiry dateJan 20, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a compound which is represented by the following general formula and has type 4 phosphodiesterase inhibitory action, and uses and an intermediate compound thereof.(wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.